Importantly, these benefits were seen across different conditions (obesity, Type 2 diabetes and even prediabetes) and ages
Your medical history: Some medical conditions may make one option safer than the other
The FDA has approved several GLP-1 medications including liraglutide (Victoza, Saxenda), dulaglutide (Trulicity), semaglutide (Ozempic, Wegovy, Rybelsus), and tirzepatide (Mounjaro, Zepbound)though tirzepatide is technically a dual GIP/GLP-1 receptor agonist
The complementary beneficial effect of this combination is depicted in Fig
To help children be seen and treated more quickly, some rooms will be dedicated to patients with less serious conditions such as sore throats and sprains
[DOI] [PMC free article] [PubMed] [Google Scholar] 36.Quinn LM, Davies MJ, Northern A et al (2021) Use of MyDesmond digital education programme to support self-management in people with type 2 diabetes during the COVID-19 pandemic